Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
暂无分享,去创建一个
[1] K. Zhu,et al. The cancer/testis antigen HORMAD1 mediates epithelial–mesenchymal transition to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway in lung cancer , 2022, Cell death discovery.
[2] Y. Pommier,et al. Cancer/Testis Antigen 55 is required for cancer cell proliferation and mitochondrial DNA maintenance. , 2022, Mitochondrion.
[3] D. Hanahan. Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.
[4] Xiangyun Wu,et al. Correlation between promoter methylation of the LDH-C4 gene and DNMT expression in breast cancer and their prognostic significance. , 2021, Oncology letters.
[5] Allen W. Zhang,et al. Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma , 2020, The Journal of clinical investigation.
[6] Rui Li,et al. TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6 , 2021, Journal of immunology research.
[7] Caroline L. Wilson,et al. Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12 , 2021, Communications Biology.
[8] Wenjie Zhu,et al. Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma , 2021, Nature Communications.
[9] Yini Wang,et al. TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis , 2021, Frontiers in Oncology.
[10] Ghaneya Al-Khadairi,et al. Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential , 2021, Journal of cellular and molecular medicine.
[11] Sanjeev Das,et al. PRAMEF2-mediated dynamic regulation of YAP signaling promotes tumorigenesis , 2021, Proceedings of the National Academy of Sciences.
[12] M. Bhadra,et al. BORIS/CTCFL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma. , 2021, Free radical biology & medicine.
[13] T. Tan,et al. GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility. , 2021, Cell reports.
[14] P. Ren,et al. CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin , 2021, Cell Death & Disease.
[15] J. Llovet,et al. Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma , 2021, PLoS genetics.
[16] Deepak Pathak,et al. The CAGE–MiR-181b-5p–S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells , 2021, Frontiers in Cell and Developmental Biology.
[17] O. Fedorova,et al. SEMG1/2 augment energy metabolism of tumor cells , 2020, Cell Death & Disease.
[18] D. Goudenège,et al. Cancer/Testis Antigens into mitochondria: a hub between spermatogenesis, tumorigenesis and mitochondrial physiology adaptation. , 2020, Mitochondrion.
[19] Taosheng Chen,et al. Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases , 2020, Nature Communications.
[20] Prashant Mishra,et al. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma , 2020, eLife.
[21] Xu Yang,et al. CSAG2 is a cancer‐specific activator of SIRT1 , 2020, EMBO reports.
[22] L. Lum,et al. Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. , 2020, Cell reports.
[23] Ying Ma,et al. MAGEA3 promotes proliferation and suppresses apoptosis in cervical cancer cells by inhibiting the KAP1/p53 signaling pathway. , 2020, American journal of translational research.
[24] Shondra M. Pruett-Miller,et al. Translational Repression of G3BP in Cancer and Germ Cells Suppresses Stress Granules and Enhances Stress Tolerance. , 2020, Molecular cell.
[25] Lin-Yu Lu,et al. Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8–MCM9 complex and compromises DNA mismatch repair in cancer cells , 2020, Cell Death & Disease.
[26] Jie Luo,et al. SPAG6 silencing induces autophagic cell death in SKM-1 cells via the AMPK/mTOR/ULK1 signaling pathway , 2020, Oncology letters.
[27] Y. Byun,et al. Crosstalk between Stress Granules, Exosomes, Tumour Antigens, and Immune Cells: Significance for Cancer Immunity , 2020, Vaccines.
[28] Jill M. Westcott,et al. The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer , 2020, bioRxiv.
[29] S. Uddin,et al. Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy , 2020, Journal of Translational Medicine.
[30] Zhaolei Cui,et al. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[31] Kate L. Hertweck,et al. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles , 2019, Scientific Reports.
[32] Bandana Sharma,et al. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells , 2019, Nature.
[33] E. Dmitrovsky,et al. Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy , 2019, Molecular Cancer Therapeutics.
[34] Ghaneya Al-Khadairi,et al. Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME? , 2019, Cancers.
[35] Shondra M. Pruett-Miller,et al. MAGE cancer-testis antigens protect the mammalian germline under environmental stress , 2019, Science Advances.
[36] Baorui Liu,et al. Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects , 2019, Translational oncology.
[37] Ran Ma,et al. GAGE7B promotes tumor metastasis and growth via activating the p38δ/pMAPKAPK2/pHSP27 pathway in gastric cancer , 2019, Journal of experimental & clinical cancer research : CR.
[38] Yu Zeng,et al. PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway , 2019, Journal of experimental & clinical cancer research : CR.
[39] Allen W. Zhang,et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers , 2018, Proceedings of the National Academy of Sciences.
[40] Ghaneya Al-Khadairi,et al. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer , 2019, Journal of Translational Medicine.
[41] D. Jeoung,et al. Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance , 2018, International journal of molecular sciences.
[42] D. Jeoung,et al. CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells , 2018, Front. Oncol..
[43] T. Yuen,et al. FSIP1 regulates autophagy in breast cancer , 2018, Proceedings of the National Academy of Sciences.
[44] Ying Wang,et al. Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment , 2018, International journal of medical sciences.
[45] S. Mowla,et al. Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma , 2018, Cancer management and research.
[46] William Y. Kim,et al. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells , 2018, Scientific Reports.
[47] Angelique W Whitehurst,et al. Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors. , 2018, Trends in cancer.
[48] Qi Hao,et al. TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231 , 2018, PloS one.
[49] A. Davis,et al. HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress. , 2018, Cancer research.
[50] Jian Wang,et al. BAP31, a newly defined cancer/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression , 2018, Cell Death & Disease.
[51] J. Koster,et al. Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development , 2018, Oncogene.
[52] D. Bedognetti,et al. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives , 2018, Front. Immunol..
[53] Hongming Zhang,et al. Current status and future directions of cancer immunotherapy , 2018, Journal of Cancer.
[54] N. Hacohen,et al. Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade , 2018, Cell.
[55] Jianfeng Xu,et al. TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese , 2017, The Prostate.
[56] S. Larson,et al. In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME) , 2017, Oncotarget.
[57] T. Yuen,et al. FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness , 2017, Proceedings of the National Academy of Sciences.
[58] P. Hwu,et al. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes , 2017, Clinical Sarcoma Research.
[59] G. Iezzi,et al. MAGE-A Antigens and Cancer Immunotherapy , 2017, Front. Med..
[60] T. Mak,et al. Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer , 2017, Proceedings of the National Academy of Sciences.
[61] Pu Li,et al. Expression of lactate dehydrogenase C correlates with poor prognosis in renal cell carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[62] C. Turtle,et al. Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies , 2017, Drugs.
[63] Q. Sun,et al. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival , 2016, Oncotarget.
[64] Christopher J. Ott,et al. ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication , 2016, Oncotarget.
[65] E. Lalli,et al. FATE1 antagonizes calcium‐ and drug‐induced apoptosis by uncoupling ER and mitochondria , 2016, EMBO reports.
[66] D. Spandidos,et al. The molecular basis of fertilization (Review) , 2016, International journal of molecular medicine.
[67] S. Knapp,et al. Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells , 2016, Journal of molecular cell biology.
[68] K. Pearce,et al. A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis , 2016, Nature Communications.
[69] M. Gjerstorff,et al. Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability , 2016, International journal of molecular sciences.
[70] Donghong Lin,et al. Expression of lactate dehydrogenase C in MDA‑MB‑231 cells and its role in tumor invasion and migration. , 2016, Molecular medicine reports.
[71] Jill M. Westcott,et al. The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion , 2016, Oncotarget.
[72] H. Ditzel,et al. The role of GAGE cancer/testis antigen in metastasis: the jury is still out , 2016, BMC Cancer.
[73] J. Weon,et al. The MAGE protein family and cancer. , 2015, Current opinion in cell biology.
[74] T. Mak,et al. Targeting Mitosis in Cancer: Emerging Strategies. , 2015, Molecular cell.
[75] Xian-Jin Xie,et al. Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer , 2015, Nature Communications.
[76] Jian Huang,et al. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells , 2015, Oncotarget.
[77] T. Gajewski. The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment. , 2015, Seminars in oncology.
[78] Seok-Hyung Kim,et al. GAGE12 mediates human gastric carcinoma growth and metastasis , 2015, International journal of cancer.
[79] A. Ashworth,et al. Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. , 2015, Cancer discovery.
[80] M. White,et al. Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase , 2015, Cell.
[81] C. Chang,et al. High throughput quantitative reverse transcription PCR assays revealing over‐expression of cancer testis antigen genes in multiple myeloma stem cell‐like side population cells , 2014, British journal of haematology.
[82] S. Hanash,et al. A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets. , 2014, Cancer research.
[83] M. Fassan,et al. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells , 2014, British Journal of Cancer.
[84] Y. Pan,et al. CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis , 2014, Cell Death and Disease.
[85] B. Brodin,et al. Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells , 2014, PloS one.
[86] Fan Yang,et al. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis , 2014, Breast Cancer Research and Treatment.
[87] Angelique W Whitehurst,et al. Cause and consequence of cancer/testis antigen activation in cancer. , 2014, Annual review of pharmacology and toxicology.
[88] S. Rosenberg,et al. Exploiting the curative potential of adoptive T‐cell therapy for cancer , 2014, Immunological reviews.
[89] J. Debnath,et al. Autophagy and cancer metabolism. , 2014, Methods in enzymology.
[90] Prakash Kulkarni,et al. Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production. , 2013, American journal of clinical and experimental urology.
[91] Yun‐Sil Lee,et al. miR-200b and Cancer/Testis Antigen CAGE Form a Feedback Loop to Regulate the Invasion and Tumorigenic and Angiogenic Responses of a Cancer Cell Line to Microtubule-targeting Drugs* , 2013, The Journal of Biological Chemistry.
[92] T. Graves,et al. Independent specialization of the human and mouse X chromosomes for the male germline , 2013, Nature Genetics.
[93] J. Grichnik,et al. Potential Role of Meiosis Proteins in Melanoma Chromosomal Instability , 2013, Journal of skin cancer.
[94] T. Kondo,et al. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene. , 2013, Tissue antigens.
[95] H. Ditzel,et al. GAGE Cancer-Germline Antigens Are Recruited to the Nuclear Envelope by Germ Cell-Less (GCL) , 2012, PloS one.
[96] Angelique W Whitehurst,et al. Multiple Cancer Testis Antigens Function To Support Tumor Cell Mitotic Fidelity , 2012, Molecular and Cellular Biology.
[97] F. Couch,et al. Tex14, a Plk1-regulated protein, is required for kinetochore-microtubule attachment and regulation of the spindle assembly checkpoint. , 2012, Molecular cell.
[98] Diego Miranda-Saavedra,et al. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer , 2012, Nature Communications.
[99] Yao-Tseng Chen. The journey from autologous typing to SEREX, NY-ESO-1, and cancer/testis antigens. , 2012, Cancer immunity.
[100] K. Miyagawa,et al. Synaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2 , 2011, EMBO reports.
[101] K. Rajagopalan,et al. A majority of the cancer/testis antigens are intrinsically disordered proteins , 2011, Journal of cellular biochemistry.
[102] Marc Buyse,et al. Adjuvant trastuzumab in HER2-positive breast cancer. , 2011, The New England journal of medicine.
[103] J. de Vos,et al. Dissecting the First Transcriptional Divergence During Human Embryonic Development , 2011, Stem Cell Reviews and Reports.
[104] S. Ely,et al. MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin , 2011, Clinical Cancer Research.
[105] E. Gabrielson,et al. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells , 2011, Proceedings of the National Academy of Sciences.
[106] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[107] M. Raffeld,et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[108] Yanan He,et al. The Cancer/Testis Antigen Prostate-associated Gene 4 (PAGE4) Is a Highly Intrinsically Disordered Protein* , 2011, The Journal of Biological Chemistry.
[109] D. Rossell,et al. Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila , 2010, Science.
[110] T. Hupp,et al. Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. , 2010, Cancer research.
[111] M. Zago,et al. Cancer/Testis antigen expression on mesenchymal stem cells isolated from different tissues. , 2010, Anticancer research.
[112] L. Girard,et al. Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation. , 2010, Cancer research.
[113] Maojun Yang,et al. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. , 2010, Molecular cell.
[114] Yun‐Sil Lee,et al. Cancer/Testis Antigen CAGE Exerts Negative Regulation on p53 Expression through HDAC2 and Confers Resistance to Anti-cancer Drugs* , 2010, The Journal of Biological Chemistry.
[115] K. Odunsi,et al. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. , 2010, Future oncology.
[116] Qiang Yu,et al. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells , 2009, Molecular Cancer Therapeutics.
[117] F. Yehiely,et al. GAGE, an antiapoptotic protein binds and modulates the expression of nucleophosmin/B23 and interferon regulatory factor 1. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[118] Martin A. Cheever,et al. The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research , 2009, Clinical Cancer Research.
[119] Robert S Illingworth,et al. CpG islands – ‘A rough guide’ , 2009, FEBS letters.
[120] Ricky W. Johnstone,et al. Epigenetics in cancer: Targeting chromatin modifications , 2009, Molecular Cancer Therapeutics.
[121] O. Gangisetty,et al. Distinct Roles for Histone Methyltransferases G9a and GLP in Cancer Germ-Line Antigen Gene Regulation in Human Cancer Cells and Murine Embryonic Stem Cells , 2009, Molecular Cancer Research.
[122] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[123] J. Mohler,et al. Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP , 2009, Molecular Cancer Research.
[124] D. Jeoung,et al. CAGE, a cancer/testis antigen, induces c-FLIPL and Snail to enhance cell motility and increase resistance to an anti-cancer drug , 2009, Biotechnology Letters.
[125] Xiaohua Hu,et al. Novel centrosome protein, TCC52, is a cancer‐testis antigen , 2008, Cancer science.
[126] D. Schübeler,et al. DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity , 2008, The EMBO journal.
[127] H. Kimura,et al. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription , 2008, The EMBO journal.
[128] H. Ditzel,et al. Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation. , 2008, Human reproduction.
[129] C. Bokemeyer,et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.
[130] Hidde L. Ploegh,et al. The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.
[131] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[132] K. Mclaughlin,et al. Mouse TEX15 is essential for DNA double-strand break repair and chromosomal synapsis during male meiosis , 2008, The Journal of cell biology.
[133] R. Medema,et al. Mps1 Phosphorylates Borealin to Control Aurora B Activity and Chromosome Alignment , 2008, Cell.
[134] D. Loukinov,et al. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors , 2007, Nucleic acids research.
[135] A. Simpson,et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. , 2007, Cancer research.
[136] Wilfred A. Jefferies,et al. Epigenetic Control of the Immune Escape Mechanisms in Malignant Carcinomas , 2007, Molecular and Cellular Biology.
[137] K. Pantel,et al. Methyl-CpG Binding Domain Proteins and Their Involvement in the Regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 Gene Promoters , 2007, Molecular Cancer Research.
[138] D. Schrump,et al. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells , 2007, Oncogene.
[139] Michael Peyton,et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.
[140] Yusuke Nakamura,et al. Oncogenic Role of MPHOSPH1, a Cancer-Testis Antigen Specific to Human Bladder Cancer , 2007 .
[141] B. Brodin,et al. Concise Review: Cancer/Testis Antigens, Stem Cells, and Cancer , 2007, Stem cells.
[142] R. Foisner,et al. LAP2α-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit , 2007, Journal of Cell Science.
[143] A. Simpson,et al. Cancer/testis (CT) antigens are expressed in fetal ovary. , 2007, Cancer immunity.
[144] K. Odunsi,et al. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. , 2007, Cancer immunity.
[145] Petra A. Link,et al. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b , 2006, Oncogene.
[146] A. Simpson,et al. PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma. , 2006, Leukemia research.
[147] G. Fang,et al. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. , 2006, Molecular biology of the cell.
[148] M. Pierotti,et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[149] A. Karpf. A Potential Role for Epigenetic Modulatory Drugs in the Enhancement of Cancer/Germ-Line Antigen Vaccine Efficacy , 2006, Epigenetics.
[150] Lisa M. Ebert,et al. Directions in the immune targeting of cancer: Lessons learned from the cancer‐testis Ag NY‐ESO‐1 , 2006, Immunology and cell biology.
[151] K. Pantel,et al. Promoter Demethylation and Histone Acetylation Mediate Gene Expression of MAGE-A1, -A2, -A3, and -A12 in Human Cancer Cells , 2006, Molecular Cancer Research.
[152] T. Boon,et al. Transient Down-regulation of DNMT1 Methyltransferase Leads to Activation and Stable Hypomethylation of MAGE-A1 in Melanoma Cells* , 2006, Journal of Biological Chemistry.
[153] I. Davis,et al. Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage , 2006, Clinical Cancer Research.
[154] R. Bernards,et al. The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling , 2005, Cell.
[155] Lloyd J. Old,et al. Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.
[156] Tsutomu Ohta,et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. , 2005, Genes & development.
[157] David L. Steffen,et al. The DNA sequence of the human X chromosome , 2005, Nature.
[158] B. Brodin,et al. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. , 2005, Cancer research.
[159] Bin He,et al. Melanoma Antigen Gene Protein MAGE-11 Regulates Androgen Receptor Function by Modulating the Interdomain Interaction , 2005, Molecular and Cellular Biology.
[160] Pierre van der Bruggen,et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family , 2005, Immunogenetics.
[161] G. Schuler,et al. Melanoma or not? Cancer testis antigens may help , 2004, The British journal of dermatology.
[162] H. Feng,et al. Localization and expression of TSP50 protein in human and rodent testes. , 2004, Urology.
[163] Mark Shackleton,et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[164] F. Berthold,et al. The Tumor-Associated Antigen PRAME Is Universally Expressed in High-Stage Neuroblastoma and Associated with Poor Outcome , 2004, Clinical Cancer Research.
[165] F. Tanaka,et al. Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune Response , 2004, Clinical Cancer Research.
[166] H. Frierson,et al. Genomic Organization, Incidence, and Localization of the SPAN-X Family of Cancer-Testis Antigens in Melanoma Tumors and Cell Lines , 2004, Clinical Cancer Research.
[167] R. Vessella,et al. Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.
[168] A. Simpson,et al. The cancer/testis genes: review, standardization, and commentary. , 2004, Cancer immunity.
[169] S. Courtois,et al. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene , 2004, Immunogenetics.
[170] T. Boon,et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. , 2004, Nucleic acids research.
[171] A. Reymond,et al. The TPTE gene family: cellular expression, subcellular localization and alternative splicing. , 2003, Gene.
[172] Robert L Strausberg,et al. Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes , 2003, Oncogene.
[173] F. Raaphorst. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. , 2003, Trends in immunology.
[174] P. Hermonat,et al. Immunolocalization of Sperm Protein 17 in Human Testis and Ejaculated Spermatozoa , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[175] T. Graves,et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes , 2003, Nature.
[176] E. Salmon,et al. hNuf2 inhibition blocks stable kinetochore–microtubule attachment and induces mitotic cell death in HeLa cells , 2002, The Journal of cell biology.
[177] H. Kato,et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. , 2002, Genes & development.
[178] J. Sidney,et al. Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design. , 2002, Cancer research.
[179] F. Yehiely,et al. A Member of the GAGE Family of Tumor Antigens is an Anti-Apoptotic Gene that Confers Resistance to Fas/CD95/APO-1, Interferon-g, Taxol and g-irradiation , 2002, Cancer biology & therapy.
[180] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[181] Pierre Morel,et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[182] M. Bertrand,et al. An overview of the MAGE gene family with the identification of all human members of the family. , 2001, Cancer research.
[183] J. Labbé,et al. Mps1 Is a Kinetochore-Associated Kinase Essential for the Vertebrate Mitotic Checkpoint , 2001, Cell.
[184] L. Old,et al. Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. , 2001, Cancer immunity.
[185] S. Rosenberg,et al. Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules , 2000, The Journal of Immunology.
[186] T. Boon,et al. Identification on a human sarcoma of two new genes with tumor-specific expression. , 2000, Cancer research.
[187] T. Boon,et al. MAGE‐B5, MAGE‐B6, MAGE‐C2, and MAGE‐C3: four new members of the MAGE family with tumor‐specific expression , 2000, International journal of cancer.
[188] Yao-Tseng Chen,et al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours , 2000, British Journal of Cancer.
[189] F. Gudat,et al. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens , 2000, British Journal of Cancer.
[190] D. Jäger,et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[191] D. Page,et al. A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins. , 2000, Human molecular genetics.
[192] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[193] Thierry Boon,et al. DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter , 1999, Molecular and Cellular Biology.
[194] P. Freemont,et al. SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex , 1999, Oncogene.
[195] D. Brett,et al. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. , 1999, Human molecular genetics.
[196] Millard,et al. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells , 1998, British journal of haematology.
[197] M. Pfreundschuh,et al. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[198] Lloyd J. Old,et al. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.
[199] K. Arden,et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. , 1998, Cancer research.
[200] D. Jäger,et al. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes , 1998, The Journal of experimental medicine.
[201] A. Monaco,et al. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. , 1997, Genomics.
[202] J. Lopes,et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. , 1997, Human molecular genetics.
[203] Yao-Tseng Chen,et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[204] S. Keeney,et al. Meiosis-Specific DNA Double-Strand Breaks Are Catalyzed by Spo11, a Member of a Widely Conserved Protein Family , 1997, Cell.
[205] P. Coulie,et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. , 1997, Immunity.
[206] J Isola,et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. , 1997, Cancer research.
[207] R. Hartsock,et al. Metastatic phenotype correlates with high expression of membrane‐associated complete β‐human chorionic gonadotropin in vivo , 1996, Cancer.
[208] F. Garrido,et al. Methylated CpG points identified within MAGE‐1 promoter are involved in gene repression , 1996, International journal of cancer.
[209] O. de Backer,et al. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[210] M. Pfreundschuh,et al. Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[211] R. Hartsock,et al. Human chorionic gonadotropin‐beta subunit gene expression in cultured human fetal and cancer cells of different types and origins , 1995, Cancer.
[212] A. Poustka,et al. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. , 1995, Genomics.
[213] O. de Backer,et al. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma , 1995, The Journal of experimental medicine.
[214] A. Monaco,et al. Isolation and characterization of a MAGE gene family in the Xp21.3 region. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[215] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[216] R. Brasseur,et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. , 1995, Immunity.
[217] M. Herlyn,et al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. , 1994, Cancer research.
[218] G. Mills,et al. Expression of TTK, a novel human protein kinase, is associated with cell proliferation. , 1992, The Journal of biological chemistry.
[219] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[220] L. Old. Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. , 1981, Cancer research.
[221] M. Pfreundschuh,et al. Cell surface antigens of human renal cancer defined by autologous typing , 1979, The Journal of experimental medicine.
[222] M. Pfreundschuh,et al. Serological analysis of cell surface antigens of malignant human brain tumors. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[223] L. Old,et al. Detection of antibody to autologous human leukemia cells by immune adherence assays. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[224] L. Old,et al. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics , 1977, The Journal of experimental medicine.
[225] H. Oettgen,et al. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens , 1976, The Journal of experimental medicine.
[226] L. Old,et al. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[227] C. Gurchot. The trophoblast theory of cancer (John Beard, 1857-1924) revisited. , 1975, Oncology.
[228] M. Kripke,et al. Antigenicity of murine skin tumors induced by ultraviolet light. , 1974, Journal of the National Cancer Institute.
[229] G. Klein,et al. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. , 1960, Cancer research.
[230] R. Prehn,et al. Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.
[231] E. J. Foley. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. , 1953, Cancer research.